Navigation Links
Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
Date:7/11/2013

LA JOLLA, Calif. (PRWEB) July 11, 2013

WHAT: CHI-California Healthcare Institute is hosting Pipeline for Life: Revitalizing Our Biomedical Research Ecosystem for a Healthier Tomorrow in La Jolla, California. Sequestration is putting enormous pressure on government funding for research programs that form the scientific base for innovative medical advances for patients.

WHO: Top academic leaders and industry executives from: Allergan, Bristol-Myers Squibb, Cedars-Sinai, Bay City Capital, Genzyme, The Scripps Research Institute, J. Gladstone Institutes, Gilead Sciences, Bay City Capital, City of Hope, Thermo Fisher Scientific, Health and policy experts from CHI, University of California, Irvine, University of California, San Diego and more.

WHY: At Pipeline for Life, California Healthcare Institute (CHI) will convene an extraordinary group of biomedical industry leaders and influential policymakers for focused discussions on success in basic research, public policy, modernizing innovation and strategy while reshaping the market for medical innovation and research inspiration for success in new therapies and medical technologies. This event brings together representatives from CHI’s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the Pipeline for Life is to produce a clearer understanding of the biomedical community’s work and needs, and how the industry can sustain California’s leadership in biomedical research and innovation.

WHO SHOULD ATTEND: Leaders from California’s biomedical industry, academic research community, entrepreneurs, healthcare providers, investors, members of the media, policy experts and patient advocates.

WHEN: Monday, July 15, 2013
Registration: 11:30 a.m. – noon
Welcoming Lunch: noon - 1:10 p.m.
Panel discussions and keynotes: 1:15 – 5:00 p.m.
Reception: 5–6 p.m.

WHERE: The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California

For more information, visit chi.org/events

Media Inquiries & Event Registration:
Erica Hiar
202-974-6322
Hiar(at)chi(dot)org

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10918157.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Crowdfunding Expert Kendall Almerico Discusses Crowdfunding for Science
2. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
3. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
4. NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
5. Patheon to Host Complimentary Seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”
6. NIH Saves Lives: Fred Hutchinson Cancer Research Center Calls On Congress To Restore Full NIH Funding
7. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
8. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
9. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
10. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
11. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on ... of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ... is expected to deliver therapeutic levels of olanzapine for a period of 3 months., ...
(Date:2/24/2017)... SAN DIEGO , Feb. 24, 2017  Aethlon ... the following note authored by its Chairman and CEO, ... address at the Munich Security Conference last Saturday, ... engineered virus could kill more people than nuclear weapons. ... by U.S. and U.K. intelligence agencies, that scientific terrorists ...
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... unaudited financial results for the third quarter and first ... 2016. Third Quarter of Fiscal 2017 Highlights ... fiscal 2017 increased by 18.6% to RMB200.9 million ($28.9 ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
Breaking Biology Technology:
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):